hábit Labs · Devolve Corp
Certificate of Analysis
FOR RESEARCH PURPOSES ONLY. This material is supplied for in-vitro laboratory research by qualified researchers. It shall not be used for human therapeutic purposes and is not for human or veterinary consumption. It is not a drug, supplement, cosmetic, food additive, or medical device.
Product identification
ProductTesamorelin 10mg
DescriptionStabilized GHRH(1-44) analog
Lot numberTES-2606-A
Release dateJun 2026
Molecular formulaC₂₂₁H₃₆₆N₇₂O₆₇S
AppearanceLyophilized powder
Storage−20 °C, protected from light
ManufacturerDevolve Corp d/b/a hábit · Ft. Lauderdale, FL
Analytical results
Identity (LC-MS)Confirmed✓ Pass
Purity (HPLC)99.2%✓ Pass
Mass spec (MW)5,135.9✓ Pass
Endotoxin (LAL)<0.5 EU/mg✓ Pass
AppearanceWhite cake✓ Pass
LC-MS identity, HPLC purity (≥99%), mass spec confirmation against 5,135.9 g/mol, endotoxin by LAL, appearance. Third-party ISO-17025 verified.
Specifications
CAS218949-48-5
Molecular formulaC₂₂₁H₃₆₆N₇₂O₆₇S
Molecular weight5,135.9 g/mol
FormLyophilized
Purity≥99% by HPLC
Endotoxin<0.5 EU/mg
Available dosages10mg
Lot prefixTES-
Storage & handling
Lyophilized: −20°C, 24 months. Reconstituted: 2–8°C, use within 14 days — like other GHRH analogs, tesamorelin is more stable lyophilized than in solution. Reconstitute with bacteriostatic water; protect from light.